Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,576 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

NCT02343042

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Jonnsson Comprehensive Cancer Center / University of Los Angeles Los Angeles, California, United States
  • Sarah Cannon-Colorado Blood Cancer Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Eastbourne District General Hospital Eastbourne, United Kingdom
  • St James University Hospital Leeds, United Kingdom
  • The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom
View Trial Details
Recruiting

OM336 in Autoimmune Cytopenias

NCT07083960

Conditions
AIHA - Cold Autoimmune Hemolytic Anemia, AIHA - Warm Autoimmune Hemolytic Anemia, Anemia, +21 more
Locations
  • The Canberra Hospital Canberra, Australian Capital Territory, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Icon Cancer Center South Brisbane Brisbane, Queensland, Australia
View Trial Details
Recruiting

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

NCT06182774

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 28 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions
Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details
Recruiting

DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

NCT07623525

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +14 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Scientia Clinical Research Ltd Randwick, New South Wales, Australia
  • Doherty Clinical Trials East Melbourne, Victoria, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details

Related conditions